Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

WST vs ATR vs GTLS vs AVTR vs AMCR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WST
West Pharmaceutical Services, Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$23.20B
5Y Perf.+49.0%
ATR
AptarGroup, Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$8.05B
5Y Perf.+12.3%
GTLS
Chart Industries, Inc.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$9.93B
5Y Perf.+428.4%
AVTR
Avantor, Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$5.67B
5Y Perf.-56.2%
AMCR
Amcor plc

Packaging & Containers

Consumer CyclicalNYSE • CH
Market Cap$18.45B
5Y Perf.+291.1%

WST vs ATR vs GTLS vs AVTR vs AMCR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WST logoWST
ATR logoATR
GTLS logoGTLS
AVTR logoAVTR
AMCR logoAMCR
IndustryMedical - Instruments & SuppliesMedical - Instruments & SuppliesIndustrial - MachineryMedical - Instruments & SuppliesPackaging & Containers
Market Cap$23.20B$8.05B$9.93B$5.67B$18.45B
Revenue (TTM)$3.22B$3.87B$4.26B$6.55B$22.19B
Net Income (TTM)$543M$387M$40M$-551M$678M
Gross Margin36.2%21.9%32.6%32.1%18.5%
Operating Margin20.7%13.0%8.5%-4.3%6.4%
Forward P/E37.3x22.5x16.4x10.6x10.1x
Total Debt$417M$1.53B$3.74B$3.95B$15.01B
Cash & Equiv.$791M$402M$366M$365M$827M

WST vs ATR vs GTLS vs AVTR vs AMCRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WST
ATR
GTLS
AVTR
AMCR
StockMay 20May 26Return
West Pharmaceutical… (WST)100149.0+49.0%
AptarGroup, Inc. (ATR)100112.3+12.3%
Chart Industries, I… (GTLS)100528.4+428.4%
Avantor, Inc. (AVTR)10043.8-56.2%
Amcor plc (AMCR)100391.1+291.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: WST vs ATR vs GTLS vs AVTR vs AMCR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AMCR leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and dividend income and shareholder returns. West Pharmaceutical Services, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. ATR and GTLS also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
WST
West Pharmaceutical Services, Inc.
The Growth Play

WST is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 6.3%, EPS growth 1.6%, 3Y rev CAGR 2.1%
  • 16.9% margin vs AVTR's -8.4%
  • 13.2% ROA vs AVTR's -4.6%, ROIC 17.5% vs -2.0%
Best for: growth exposure
ATR
AptarGroup, Inc.
The Income Pick

ATR ranks third and is worth considering specifically for income & stability and sleep-well-at-night.

  • Dividend streak 33 yrs, beta 0.66, yield 1.4%
  • Lower volatility, beta 0.66, Low D/E 56.4%, current ratio 1.62x
  • PEG 1.75 vs WST's 4.51
  • Beta 0.66, yield 1.4%, current ratio 1.62x
Best for: income & stability and sleep-well-at-night
GTLS
Chart Industries, Inc.
The Long-Run Compounder

GTLS is the clearest fit if your priority is long-term compounding.

  • 7.7% 10Y total return vs AMCR's 417.0%
  • Beta 0.56 vs AVTR's 1.54
Best for: long-term compounding
AVTR
Avantor, Inc.
The Value Angle

Among these 5 stocks, AVTR doesn't own a clear edge in any measured category.

Best for: healthcare exposure
AMCR
Amcor plc
The Growth Leader

AMCR carries the broadest edge in this set and is the clearest fit for growth and dividends.

  • 10.0% revenue growth vs AVTR's -3.4%
  • 6.6% yield, 11-year raise streak, vs ATR's 1.4%, (1 stock pays no dividend)
  • +366.6% vs AVTR's -30.4%
Best for: growth and dividends
See the full category breakdown
CategoryWinnerWhy
GrowthAMCR logoAMCR10.0% revenue growth vs AVTR's -3.4%
ValueATR logoATRBetter valuation composite
Quality / MarginsWST logoWST16.9% margin vs AVTR's -8.4%
Stability / SafetyGTLS logoGTLSBeta 0.56 vs AVTR's 1.54
DividendsAMCR logoAMCR6.6% yield, 11-year raise streak, vs ATR's 1.4%, (1 stock pays no dividend)
Momentum (1Y)AMCR logoAMCR+366.6% vs AVTR's -30.4%
Efficiency (ROA)WST logoWST13.2% ROA vs AVTR's -4.6%, ROIC 17.5% vs -2.0%

WST vs ATR vs GTLS vs AVTR vs AMCR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

WSTWest Pharmaceutical Services, Inc.
FY 2025
Proprietary Products
81.1%$2.5B
Contract Manufactured Products
18.9%$582M
ATRAptarGroup, Inc.
FY 2025
Pharma Segment
57.0%$1.7B
Beauty Segment
43.0%$1.3B
GTLSChart Industries, Inc.
FY 2025
Repair, Service And Leasing Segment
30.6%$1.3B
Heat Transfer Systems Segment
29.0%$1.2B
Specialty Products Segment
25.8%$1.1B
Cryo Tank Solutions Segment
14.6%$624M
AVTRAvantor, Inc.
FY 2025
Proprietary Materials And Consumables
52.6%$3.4B
Third Party Materials And Consumables
47.4%$3.1B
AMCRAmcor plc
FY 2025
Flexibles Segment
72.4%$10.9B
Rigid Packaging Segment
27.6%$4.1B

WST vs ATR vs GTLS vs AVTR vs AMCR — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLWSTLAGGINGATR

Income & Cash Flow (Last 12 Months)

WST leads this category, winning 5 of 6 comparable metrics.

AMCR is the larger business by revenue, generating $22.2B annually — 6.9x WST's $3.2B. WST is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to AVTR's -8.4%. On growth, AMCR holds the edge at +77.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricWST logoWSTWest Pharmaceutic…ATR logoATRAptarGroup, Inc.GTLS logoGTLSChart Industries,…AVTR logoAVTRAvantor, Inc.AMCR logoAMCRAmcor plc
RevenueTrailing 12 months$3.2B$3.9B$4.3B$6.6B$22.2B
EBITDAEarnings before interest/tax$794M$801M$644M$137M$2.6B
Net IncomeAfter-tax profit$543M$387M$40M-$551M$678M
Free Cash FlowCash after capex$458M$325M$203M$439M$1.4B
Gross MarginGross profit ÷ Revenue+36.2%+21.9%+32.6%+32.1%+18.5%
Operating MarginEBIT ÷ Revenue+20.7%+13.0%+8.5%-4.3%+6.4%
Net MarginNet income ÷ Revenue+16.9%+10.0%+0.9%-8.4%+3.1%
FCF MarginFCF ÷ Revenue+14.2%+8.4%+4.8%+6.7%+6.5%
Rev. Growth (YoY)Latest quarter vs prior year+21.0%+10.8%-2.5%0.0%+77.4%
EPS Growth (YoY)Latest quarter vs prior year+56.1%-4.3%-36.1%-32.6%-11.8%
WST leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

AVTR leads this category, winning 4 of 7 comparable metrics.

At 21.3x trailing earnings, ATR trades at a 97% valuation discount to GTLS's 628.5x P/E. Adjusting for growth (PEG ratio), ATR offers better value at 1.65x vs WST's 5.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricWST logoWSTWest Pharmaceutic…ATR logoATRAptarGroup, Inc.GTLS logoGTLSChart Industries,…AVTR logoAVTRAvantor, Inc.AMCR logoAMCRAmcor plc
Market CapShares × price$23.2B$8.1B$9.9B$5.7B$18.4B
Enterprise ValueMkt cap + debt − cash$22.8B$9.2B$13.3B$9.3B$32.6B
Trailing P/EPrice ÷ TTM EPS47.33x21.28x628.45x-10.65x24.96x
Forward P/EPrice ÷ next-FY EPS est.37.34x22.47x16.40x10.57x10.13x
PEG RatioP/E ÷ EPS growth rate5.72x1.65x
EV / EBITDAEnterprise value multiple30.77x11.48x14.33x56.43x18.85x
Price / SalesMarket cap ÷ Revenue7.55x2.13x2.33x0.87x1.23x
Price / BookPrice ÷ Book value/share7.37x3.08x2.79x1.01x1.08x
Price / FCFMarket cap ÷ FCF49.48x26.89x48.95x11.46x22.78x
AVTR leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

WST leads this category, winning 8 of 9 comparable metrics.

ATR delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-10 for AVTR. WST carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMCR's 1.28x. On the Piotroski fundamental quality scale (0–9), WST scores 6/9 vs AMCR's 5/9, reflecting solid financial health.

MetricWST logoWSTWest Pharmaceutic…ATR logoATRAptarGroup, Inc.GTLS logoGTLSChart Industries,…AVTR logoAVTRAvantor, Inc.AMCR logoAMCRAmcor plc
ROE (TTM)Return on equity+17.9%+18.6%+1.2%-9.6%+3.7%
ROA (TTM)Return on assets+13.2%+7.6%+0.4%-4.6%+1.8%
ROICReturn on invested capital+17.5%+10.7%+7.4%-2.0%+4.1%
ROCEReturn on capital employed+18.4%+13.8%+8.6%-2.4%+4.8%
Piotroski ScoreFundamental quality 0–965555
Debt / EquityFinancial leverage0.13x0.56x1.11x0.71x1.28x
Net DebtTotal debt minus cash-$375M$1.1B$3.4B$3.6B$14.2B
Cash & Equiv.Liquid assets$791M$402M$366M$365M$827M
Total DebtShort + long-term debt$417M$1.5B$3.7B$3.9B$15.0B
Interest CoverageEBIT ÷ Interest expense3338.00x16.19x1.08x-1.55x2.85x
WST leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

AMCR leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in AMCR five years ago would be worth $42,012 today (with dividends reinvested), compared to $2,662 for AVTR. Over the past 12 months, AMCR leads with a +366.6% total return vs AVTR's -30.4%. The 3-year compound annual growth rate (CAGR) favors AMCR at 65.6% vs AVTR's -25.5% — a key indicator of consistent wealth creation.

MetricWST logoWSTWest Pharmaceutic…ATR logoATRAptarGroup, Inc.GTLS logoGTLSChart Industries,…AVTR logoAVTRAvantor, Inc.AMCR logoAMCRAmcor plc
YTD ReturnYear-to-date+16.6%+2.9%+0.6%-27.5%+382.5%
1-Year ReturnPast 12 months+51.4%-16.1%+37.6%-30.4%+366.6%
3-Year ReturnCumulative with dividends-11.6%+7.4%+62.7%-58.6%+354.2%
5-Year ReturnCumulative with dividends-2.4%-15.3%+29.5%-73.4%+320.1%
10-Year ReturnCumulative with dividends+361.4%+83.3%+772.5%-42.7%+417.0%
CAGR (3Y)Annualised 3-year return-4.0%+2.4%+17.6%-25.5%+65.6%
AMCR leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

GTLS leads this category, winning 2 of 2 comparable metrics.

GTLS is the less volatile stock with a 0.56 beta — it tends to amplify market swings less than AVTR's 1.54 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GTLS currently trades 99.5% from its 52-week high vs AVTR's 52.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWST logoWSTWest Pharmaceutic…ATR logoATRAptarGroup, Inc.GTLS logoGTLSChart Industries,…AVTR logoAVTRAvantor, Inc.AMCR logoAMCRAmcor plc
Beta (5Y)Sensitivity to S&P 5000.92x0.66x0.56x1.54x0.80x
52-Week HighHighest price in past year$323.63$164.28$208.51$15.93$50.94
52-Week LowLowest price in past year$202.79$103.23$140.50$7.26$7.67
% of 52W HighCurrent price vs 52-week peak+99.5%+76.2%+99.5%+52.2%+78.4%
RSI (14)Momentum oscillator 0–10073.242.851.258.152.3
Avg Volume (50D)Average daily shares traded835K473K1.6M8.9M5.5M
GTLS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — ATR and AMCR each lead in 1 of 2 comparable metrics.

Analyst consensus: WST as "Buy", ATR as "Buy", GTLS as "Buy", AVTR as "Hold", AMCR as "Buy". Consensus price targets imply 35.6% upside for ATR (target: $170) vs -6.5% for GTLS (target: $194). For income investors, AMCR offers the higher dividend yield at 6.64% vs WST's 0.26%.

MetricWST logoWSTWest Pharmaceutic…ATR logoATRAptarGroup, Inc.GTLS logoGTLSChart Industries,…AVTR logoAVTRAvantor, Inc.AMCR logoAMCRAmcor plc
Analyst RatingConsensus buy/hold/sellBuyBuyBuyHoldBuy
Price TargetConsensus 12-month target$315.83$169.67$193.81$9.50$50.00
# AnalystsCovering analysts1418372613
Dividend YieldAnnual dividend ÷ price+0.3%+1.4%+0.3%+6.6%
Dividend StreakConsecutive years of raises25331011
Dividend / ShareAnnual DPS$0.84$1.81$0.60$2.65
Buyback YieldShare repurchases ÷ mkt cap+0.6%+4.5%0.0%+1.4%+0.7%
Evenly matched — ATR and AMCR each lead in 1 of 2 comparable metrics.
Key Takeaway

WST leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AVTR leads in 1 (Valuation Metrics). 1 tied.

Best OverallWest Pharmaceutical Service… (WST)Leads 2 of 6 categories
Loading custom metrics...

WST vs ATR vs GTLS vs AVTR vs AMCR: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is WST or ATR or GTLS or AVTR or AMCR a better buy right now?

For growth investors, Amcor plc (AMCR) is the stronger pick with 10.

0% revenue growth year-over-year, versus -3. 4% for Avantor, Inc. (AVTR). AptarGroup, Inc. (ATR) offers the better valuation at 21. 3x trailing P/E (22. 5x forward), making it the more compelling value choice. Analysts rate West Pharmaceutical Services, Inc. (WST) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — WST or ATR or GTLS or AVTR or AMCR?

On trailing P/E, AptarGroup, Inc.

(ATR) is the cheapest at 21. 3x versus Chart Industries, Inc. at 628. 5x. On forward P/E, Amcor plc is actually cheaper at 10. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: AptarGroup, Inc. wins at 1. 75x versus West Pharmaceutical Services, Inc. 's 4. 51x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — WST or ATR or GTLS or AVTR or AMCR?

Over the past 5 years, Amcor plc (AMCR) delivered a total return of +320.

1%, compared to -73. 4% for Avantor, Inc. (AVTR). Over 10 years, the gap is even starker: GTLS returned +772. 5% versus AVTR's -42. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — WST or ATR or GTLS or AVTR or AMCR?

By beta (market sensitivity over 5 years), Chart Industries, Inc.

(GTLS) is the lower-risk stock at 0. 56β versus Avantor, Inc. 's 1. 54β — meaning AVTR is approximately 177% more volatile than GTLS relative to the S&P 500. On balance sheet safety, West Pharmaceutical Services, Inc. (WST) carries a lower debt/equity ratio of 13% versus 128% for Amcor plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — WST or ATR or GTLS or AVTR or AMCR?

By revenue growth (latest reported year), Amcor plc (AMCR) is pulling ahead at 10.

0% versus -3. 4% for Avantor, Inc. (AVTR). On earnings-per-share growth, the picture is similar: AptarGroup, Inc. grew EPS 6. 3% year-over-year, compared to -175. 0% for Avantor, Inc.. Over a 3-year CAGR, GTLS leads at 38. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — WST or ATR or GTLS or AVTR or AMCR?

West Pharmaceutical Services, Inc.

(WST) is the more profitable company, earning 16. 1% net margin versus -8. 1% for Avantor, Inc. — meaning it keeps 16. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WST leads at 20. 1% versus -3. 8% for AVTR. At the gross margin level — before operating expenses — WST leads at 35. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is WST or ATR or GTLS or AVTR or AMCR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, AptarGroup, Inc. (ATR) is the more undervalued stock at a PEG of 1. 75x versus West Pharmaceutical Services, Inc. 's 4. 51x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Amcor plc (AMCR) trades at 10. 1x forward P/E versus 37. 3x for West Pharmaceutical Services, Inc. — 27. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ATR: 35. 6% to $169. 67.

08

Which pays a better dividend — WST or ATR or GTLS or AVTR or AMCR?

In this comparison, AMCR (6.

6% yield), ATR (1. 4% yield), GTLS (0. 3% yield), WST (0. 3% yield) pay a dividend. AVTR does not pay a meaningful dividend and should not be held primarily for income.

09

Is WST or ATR or GTLS or AVTR or AMCR better for a retirement portfolio?

For long-horizon retirement investors, Amcor plc (AMCR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

80), 6. 6% yield, +417. 0% 10Y return). Avantor, Inc. (AVTR) carries a higher beta of 1. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMCR: +417. 0%, AVTR: -42. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between WST and ATR and GTLS and AVTR and AMCR?

These companies operate in different sectors (WST (Healthcare) and ATR (Healthcare) and GTLS (Industrials) and AVTR (Healthcare) and AMCR (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: WST is a mid-cap quality compounder stock; ATR is a small-cap quality compounder stock; GTLS is a small-cap quality compounder stock; AVTR is a small-cap quality compounder stock; AMCR is a mid-cap income-oriented stock. ATR, AMCR pay a dividend while WST, GTLS, AVTR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

WST

High-Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Net Margin > 10%
Run This Screen
Stocks Like

ATR

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

GTLS

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Gross Margin > 19%
Run This Screen
Stocks Like

AVTR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 19%
Run This Screen
Stocks Like

AMCR

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 38%
  • Dividend Yield > 2.6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform WST and ATR and GTLS and AVTR and AMCR on the metrics below

Revenue Growth>
%
(WST: 21.0% · ATR: 10.8%)
Net Margin>
%
(WST: 16.9% · ATR: 10.0%)
P/E Ratio<
x
(WST: 47.3x · ATR: 21.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.